Fortrea (FTRE) Tmuɣli n wazal
Ṛṛbem n lḥedd$19.90Yettwalemmaḍ 25 Sep 2026 19:59 UTC
Beddel-0.55%
Asnulfu n AI: FTRE
AI tessawal ɣef timaqsiṭ n wazal i wass n tnekkit d-iteddun, taggara n yimal akked taggara n waggʷas. Asnifel yettwamḍen seg wazal aneggaru. Aya d tinineḍ n tḥisabt, ma tga ara timsisi n usihel.
Asref n 6 isggʷasn ineggura
Premium tessaɣ-d iswiyat n tɣara n AI i wass, amalas d waggʷas n yiwen i uḍris-a akk d yisɣunan niḍen.
Serreḥ Premium🔒 Tazmilt n usenfar
Amezruy n tmuɣliyin — akk tmuɣliyin n zik akked wazal n tnekkit — d akcum n Premium.
Serreḥ PremiumƔef tneɣlaft-a
Fortrea Holdings Inc. is a holding company that specializes in managing drug clinical trials and processes that facilitate easier patient access to healthcare services. The company collaborates with both emerging and large biopharmaceutical, medical device, and diagnostic equipment companies, operating globally.
